Inclusion Criteria:
  -  The patient completed Study 17972A.
  -  The patient and the patient's caregiver or identified responsible person is able to read and understand the Informed Consent Form.
  -  The patient has signed the Informed Consent Form specific for Study 17972B.
  -  The patient can potentially benefit from 24 weeks of treatment with Lu AF11167 according to the investigator's clinical judgment.
Exclusion Criteria:
  -  The patient has any current primary psychiatric disorder other than schizophrenia diagnosed during study 17972A
  -  The patient, in the opinion of the investigator, is at significant risk of suicide
Other in- and exclusion criteria may apply